Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260182 · ClinicalTrials.gov registry record
Genetics of Recurrent Early Onset Major Depression
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 2,302
- Enrollment target
NCT00260182: Completed study, sponsored by Stanford University.
NCT00260182 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 2,302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260182 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 2,302 participants
- Enrollment target
Study Summary
This study will identify specific genes that may cause a predisposition to depression in some families.
Primary Outcome
The study will correlate genome-wide SNP genotypes with case vs. control status, defined by presence or absence of major depressive disorder. Participants will attend an interview regarding personal and family history of psychiatric disorders, and give a blood specimen. Genotypes from blood samples will be studied for association with presence of major depressive disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,302 participants |
| Start Date | 2005-10 |
| Est. Completion | 2009-06 |
What the finished NCT00260182 record still lists
NCT00260182 is an observational study that tracks outcomes without assigning an intervention. Its 2,302 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00260182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00260182 about?
NCT00260182 is a clinical study titled "Genetics of Recurrent Early Onset Major Depression". This study will identify specific genes that may cause a predisposition to depression in some families.
What is the current status of trial NCT00260182?
This trial is currently completed. The enrollment target is 2,302 participants. The study started on 2005-10. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00260182?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- NCT05759988 · 2,300 participants · NA
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia